BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/6/2020 8:20:24 AM | Browse: 1571 | Download: 2696
Publication Name World Journal of Psychiatry
Manuscript ID 52497
Country United States
ISSN 2220-3206 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Randomized Controlled Trial
Article Title Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia
Manuscript Source Invited Manuscript
All Author List Sheila M Dowd, Alyson K Zalta, Helen J Burgess, Elizabeth C Adkins, Zerbrina Valdespino-Hayden and Mark H Pollack
ORCID
Author(s) ORCID Number
Sheila M Dowd http://orcid.org/0000-0002-6032-0351
Alyson K Zalta http://orcid.org/0000-0002-5159-8431
Helen J Burgess http://orcid.org/0000-0003-3816-8194
Elizabeth C Adkins http://orcid.org/0000-0002-0651-3013
Zerbrina Valdespino-Hayden http://orcid.org/0000-0002-2188-5173
Mark H Pollack http://orcid.org/0000-0002-3990-8337
Funding Agency and Grant Number
Funding Agency Grant Number
National Institutes of Mental Health 5R34MH91338-03
National Institutes of Mental Health K23 MH103394
Corresponding Author Sheila M Dowd, PhD, Associate Professor, Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, 1645 West Jackson Blvd Suite 400, Chicago, IL 60601, United States. sheila_dowd@rush.edu
Key Words Trauma; Sleep disturbance; Hypnotic; Post-traumatic stress disorder; ;
Core Tip Sleep disturbance is a core feature of post-traumatic stress disorder (PTSD) yet few studies have examined the impact of psychopharmacotherapy. Results from this randomized controlled parallel study in individuals with PTSD and sleep disturbance did not demonstrate a significant relative improvement for eszopiclone (ESZ) vs placebo treated patients. Although patients receiving ESZ did experience significant improvement in measures of PTSD and sleep disturbance, placebo treated patients also significantly improved on these outcomes. Thus the potential role for ESZ in the treatment of PTSD remains uncertain until a larger more definitive trial is undertaken.
Publish Date 2020-03-06 08:20
Citation Dowd SM, Zalta AK, Burgess HJ, Adkins EE, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatr 2020; 10(3): 21-28
URL https://www.wjgnet.com/2220-3206/full/v10/i3/21.htm
DOI https://dx.doi.org/10.5498/wjp.v10.i3.21
Full Article (PDF) WJP-10-21.pdf
Full Article (Word) WJP-10-21.docx